{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:32:32Z","timestamp":1791048752121,"version":"4.1.0"},"reference-count":37,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T00:00:00Z","timestamp":1549843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004084","name":"Korea Science and Engineering Foundation","doi-asserted-by":"publisher","award":["HO15C0003,2015M2B2B1068627,50536-2019,50461-2018"],"award-info":[{"award-number":["HO15C0003,2015M2B2B1068627,50536-2019,50461-2018"]}],"id":[{"id":"10.13039\/501100004084","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>The authors identified that chemo-brain was induced after trastuzumab (TZB) therapy. In addition, atorvastatin (ATV) could rescue chemo-brain during trastuzumab (TZB) therapy. Enhanced therapeutic effect of TZB was confirmed after ATV therapy. We also investigated that there was no hair loss side effect due to ATV therapy. In an animal model, 150 \u03bcg TZB and five serial doses of 20 mg\/kg ATV were administered. 18F-fluorodeoxyglucose Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) data were acquired. Statistical parametric mapping analysis and voxel-based morphometry analysis were performed to identify differences in glucose metabolism and gray matter concentration. The enhanced therapeutic efficacy of TZB after ATV treatment was assessed using a human epidermal growth factor receptor 2-positive gastric cancer model. We found a decrease in cerebral glucose metabolism and gray matter concentration in the frontal lobe following TZB therapy (p &lt; 0.005). After subsequent ATV administration, glucose metabolism and regional gray matter concentration were rescued (p &lt; 0.005). Cognitive impairment due to TZB and the rescue effect of ATV were confirmed using a passive avoidance test and quantitative real-time reverse transcription PCR. Furthermore, the penetration and accumulation of TZB in tumors increased by 100% after ATV co-administration, which resulted in an enhanced anti-cancer effect. Our study collectively demonstrates that ATV co-administration with TZB rescued the TZB-induced chemo-brain and enhances the therapeutic efficacy of TZB in tumors. We also showed that there was no hair loss during ATV therapy.<\/jats:p>","DOI":"10.3390\/jcm8020234","type":"journal-article","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T03:18:20Z","timestamp":1549941500000},"page":"234","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Trastuzumab Induced Chemobrain, Atorvastatin Rescued Chemobrain with Enhanced Anticancer Effect and without Hair Loss-Side Effect"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8156-0170","authenticated-orcid":false,"given":"Seonhwa","family":"Lee","sequence":"first","affiliation":[{"name":"Division of RI Application, Korea Institute of Radiological and Medical Sciences, 75 Nowon-ro, Nowon-gu, Seoul 01812, Korea"},{"name":"Department of Bio-convergence Engineering, Korea University, Seoul 02856, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7743-0151","authenticated-orcid":false,"given":"Hae-June","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Radiation Biomedical Research, Korea Institute of Radiological and Medical Sciences, 75 Nowon-ro, Nowon-gu, Seoul 01812, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunji","family":"Kang","sequence":"additional","affiliation":[{"name":"Division of RI Application, Korea Institute of Radiological and Medical Sciences, 75 Nowon-ro, Nowon-gu, Seoul 01812, Korea"},{"name":"Radiological and Medico-Oncological Sciences, University of Science and Technology, 75 Nowon-ro, Nowon-gu, Seoul 01812, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6476-163X","authenticated-orcid":false,"given":"Eun-Ho","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Radiation Biomedical Research, Korea Institute of Radiological and Medical Sciences, 75 Nowon-ro, Nowon-gu, Seoul 01812, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2710-4737","authenticated-orcid":false,"given":"Young-Cheol","family":"Lim","sequence":"additional","affiliation":[{"name":"Division of RI Application, Korea Institute of Radiological and Medical Sciences, 75 Nowon-ro, Nowon-gu, Seoul 01812, Korea"},{"name":"Research Support Team, ANDIVA Inc., Chuncheon 24324, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6138-0092","authenticated-orcid":false,"given":"Hyejin","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Radiation Biomedical Research, Korea Institute of Radiological and Medical Sciences, 75 Nowon-ro, Nowon-gu, Seoul 01812, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8213-8174","authenticated-orcid":false,"given":"Sang Moo","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Korea Institute Radiological and Medical Sciences, 75 Nowon-ro, Nowon-gu, Seoul 01812, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Jin","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of RI Application, Korea Institute of Radiological and Medical Sciences, 75 Nowon-ro, Nowon-gu, Seoul 01812, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3691-0001","authenticated-orcid":false,"given":"Jung Min","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Bio-convergence Engineering, Korea University, Seoul 02856, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8965-9538","authenticated-orcid":false,"given":"Jin Su","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of RI Application, Korea Institute of Radiological and Medical Sciences, 75 Nowon-ro, Nowon-gu, Seoul 01812, Korea"},{"name":"Radiological and Medico-Oncological Sciences, University of Science and Technology, 75 Nowon-ro, Nowon-gu, Seoul 01812, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,2,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10120-013-0252-z","article-title":"HER2-positive gastric cancer","volume":"17","author":"Boku","year":"2014","journal-title":"Gastric Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/1758834012469429","article-title":"Gastric cancer and trastuzumab: first biologic therapy in gastric cancer","volume":"5","author":"Gunturu","year":"2013","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1093\/annonc\/12.suppl_1.S35","article-title":"Mechanism of action of anti-HER2 monoclonal antibodies","volume":"12","author":"Baselga","year":"2001","journal-title":"Ann. Oncol."},{"key":"ref_4","first-page":"122","article-title":"Recent advances in the development of anti-HER2 antibodies and antibody-drug conjugates","volume":"2","author":"Wong","year":"2014","journal-title":"Ann. Transl. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/17425255.2017.1337746","article-title":"Cardiotoxicity of ErbB2-targeted therapies and its impact on drug development, a spotlight on trastuzumab","volume":"13","author":"Dokmanovic","year":"2017","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Scandinavian Simvastatin Survival Study Group (1994). Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet, 344, 1383\u20131389.","DOI":"10.1016\/S0140-6736(94)90566-5"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia","volume":"333","author":"Shepherd","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2007.11.036","article-title":"Statins in tumor suppression","volume":"260","author":"Sassano","year":"2008","journal-title":"Cancer Lett."},{"key":"ref_9","first-page":"10","article-title":"The statins as anticancer agents","volume":"9","author":"Chan","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2012.04.011","article-title":"Statins and cancer: current and future prospects","volume":"324","author":"Osmak","year":"2012","journal-title":"Cancer Lett."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1269\/jrr.11114","article-title":"Cell killing and radiosensitizing effects of atorvastatin in PC3 prostate cancer cells","volume":"53","author":"He","year":"2012","journal-title":"J. Radiat. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.brainres.2015.10.032","article-title":"Atorvastatin attenuates cognitive deficits through Akt1\/caspase-3 signaling pathway in ischemic stroke","volume":"10","author":"Yang","year":"2015","journal-title":"Brain Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s12640-015-9527-y","article-title":"Atorvastatin prevents cognitive deficits induced by intracerebroventricular amyloid-\u03b21-40 administration in mice: involvement of glutamatergic and antioxidant systems","volume":"28","author":"Martins","year":"2015","journal-title":"Neurotox Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ahj.2017.10.027","article-title":"The effect of high-dose atorvastatin on neural activity and cognitive function","volume":"197","author":"Taylor","year":"2018","journal-title":"Am. Heart J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1200\/JCO.2012.43.0116","article-title":"Cancer- and cancer treatment-associated cognitive change: An update on the state of the science","volume":"30","author":"Ahles","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1053\/j.seminoncol.2011.03.014","article-title":"An update on cancer- and chemotherapy-related cognitive dysfunction: current status","volume":"38","author":"Janelsins","year":"2011","journal-title":"Semin. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","article-title":"Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis","volume":"155","author":"Seretny","year":"2014","journal-title":"Pain"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fnins.2015.00131","article-title":"Mechanisms of chemotherapy-induced behavioral toxicities","volume":"9","author":"Vichaya","year":"2015","journal-title":"Front. Neurosci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cyto.2014.12.006","article-title":"Chemobrain: A critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy","volume":"72","author":"Wang","year":"2015","journal-title":"Cytokine"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Lim, I.H., Joung, H.Y., Yu, A.R., Shim, I.S., and Kim, J.S. (2016). PET evidence of the effect of donepezil on cognitive performance in an animal model of chemobrain. Biomed. Res. Int.","DOI":"10.1155\/2016\/6945415"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2967\/jnumed.108.056374","article-title":"Performance evaluation of the inveon dedicated PET preclinical tomograph based on the NEMA NU-4 standards","volume":"50","author":"Bao","year":"2009","journal-title":"J. Nucl. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s11307-008-0140-9","article-title":"Assessment of cerebral glucose metabolism in cat deafness model: strategies for improving the voxel-based statistical analysis for animal PET studies","volume":"10","author":"Kim","year":"2008","journal-title":"Mol. Imaging Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/nimg.2001.0786","article-title":"A voxel-based morphometric study of ageing in 465 normal adult human brains","volume":"14","author":"Good","year":"2001","journal-title":"Neuroimage"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1361-8415(02)00054-3","article-title":"BrainSuite: an automated cortical surface identification tool","volume":"6","author":"Shattuck","year":"2002","journal-title":"Med. Image Anal."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jneumeth.2015.09.031","article-title":"A simple rapid process for semi-automated brain extraction from magnetic resonance images of the whole mouse head","volume":"257","author":"Delora","year":"2016","journal-title":"J. Neurosci. Methods"},{"key":"ref_26","first-page":"120","article-title":"Antipsychotic like effects of atorvastatin and melatonin in a psychosis model in rats","volume":"5","author":"Solmaz","year":"2015","journal-title":"J. Mood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.0022-202X.2005.23787.x","article-title":"A guide to assessing damage response pathways of the hair follicle: lessons from cyclophosphamide-induced alopecia in mice","volume":"125","author":"Hendrix","year":"2005","journal-title":"J. Investig. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1038\/srep06919","article-title":"The effect of fluorescent nanodiamonds on neuronal survival and morphogenesis","volume":"4","author":"Huang","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biopha.2017.06.033","article-title":"Targeting proinflammatory cytokines, oxidative stress, TGF-beta1 and STAT-3 by rosuvastatin and ubiquinone to ameliorate trastuzumab cardiotoxicity","volume":"93","author":"Kabel","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0028-3932(02)00200-2","article-title":"Vision for spatial perception and vision for action: a dissociation between the left-right and near-far dimensions","volume":"41","author":"Coello","year":"2003","journal-title":"Neuropsychologia"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/pon.3531","article-title":"Impact of chemotherapy-induced alopecia distress on body image, psychosocial well-being, and depression in breast cancer patients","volume":"23","author":"Choi","year":"2014","journal-title":"Psychooncology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/1874226200902010079","article-title":"Immunodeficient Mouse Models: An Overview","volume":"2","year":"2009","journal-title":"Open Immunol. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"5072","DOI":"10.18632\/oncotarget.3241","article-title":"Acquisition of resistance to trastuzumab in gastric cancer cells is associated with activation of IL-6\/STAT3\/Jagged-1\/Notch positive feedback loop","volume":"6","author":"Yang","year":"2015","journal-title":"Oncotarget"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"11228","DOI":"10.18632\/oncotarget.14495","article-title":"IL-6\/STAT3\/TWIST inhibition reverses ionizing radiation-induced EMT and radioresistance in esophageal squamous carcinoma","volume":"8","author":"Zang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s13139-015-0392-7","article-title":"Combination radioimmunotherapy approaches and quantification of immuno-PET","volume":"50","author":"Kim","year":"2016","journal-title":"Nucl. Med. Mol. Imaging"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s11011-014-9551-2","article-title":"Interleukin 6 and cognitive dysfunction","volume":"29","author":"Trapero","year":"2014","journal-title":"Metab. Brain Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.addr.2015.12.003","article-title":"Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting alpha-particles or Auger electrons","volume":"109","author":"Aghevlian","year":"2017","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/8\/2\/234\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:31:11Z","timestamp":1760185871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/8\/2\/234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,11]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,2]]}},"alternative-id":["jcm8020234"],"URL":"https:\/\/doi.org\/10.3390\/jcm8020234","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,11]]}}}